Abstract
The introduction of a color liquid–crystal display (LCD) on a novel artificial pancreas (STG-55, Nikkiso Co. Ltd. Tokyo, Japan) allowed nurses to more easily monitor changes in patients’ blood glucose levels, compared to the previous model (STG-22). This study was conducted to examine the hypothesis that the STG-55 provided nurses with a feeling of security due to the introduction of the LCD screen. A questionnaire survey was conducted 6 months after the STG-55 was introduced (Survey 2012), among intensive care unit (ICU) nurses who had used both the STG-22 and the STG-55 for patient glycemic control. The results were then compared with the results from a questionnaire survey that was conducted after the STG-22 was introduced (Survey 2006). All ICU nurses (n = 19) responded to Survey 2012, and 95 % of these nurses had responded to Survey 2006 (n = 19). After the introduction of the STG-22, 11 nurses (58 %) reported becoming conscious of anxiety regarding hypoglycemia when they performed conventional glucose control with the sliding scale method. This anxiety awareness increased significantly (19 nurses, 100 %; p < 0.01) after the STG-55 was introduced. However, there were no significant differences in the proportion of respondents who requested improvements in the blood withdrawal process. In conclusion, the results of our survey indicate that all ICU nurses became conscious of anxiety regarding the risk of hypoglycemia when using the conventional sliding scale method after the introduction of the STG-55. However, the respondents were not satisfied with the STG-55, due to difficulties encountered during blood withdrawal.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hanazaki K, Maeda H, Okabayashi T. Relationship between perioperative glycemic control and postoperative infection. World J Gastroenterol. 2009;15:4122–5.
Kawahito S, Kitahata H, Oshita S. Problems associated with glucose toxicity :role of hyperglycemia induced oxidative stress. World J Gastroenterol. 2009;15:4137–42.
Ramos M, Khalpey Z, Lipsitz S, et al. Relationship of perioperative hyperglycemia and perioperative infection in patients who undergo general and vascular surgery. Ann Surg. 2008;248:585–91.
Hanazaki K, Kitagawa H, Munekage M. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system the effects of no hypoglycemia. Am J Surg. 2014;207:935–41.
Mibu K, Yatabe T, Hanazaki K. Blood glucose control using an artificial pancreas reduces the workload of ICU nurses. J Artif Organs. 2012;15:71–6.
van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critical ill patients. N Engl J Med. 2001;345:1359–67.
Wiener Rs, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults. JAMA. 2008;300:933–44.
NICE-SUGAR study investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.
Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251–76.
Yatabe T, Yamazaki R, Kitagawa H, et al. The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients. Crit Care Med. 2011;39:575–8.
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Mibu, K., Yatabe, T., Yamasaki, F. et al. Questionnaire survey on the use of a novel artificial pancreas by intensive care unit nurses. J Artif Organs 18, 162–165 (2015). https://doi.org/10.1007/s10047-015-0818-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-015-0818-0